GHCL growth ratios

·ChemicalsChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY26Mar 2026FY25Mar 2025FY24Mar 2024FY22 and earlierAlpha Plus
−3.7%−7.6%−24.2%
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
−21.4%+3.4%−42.8%
−24.4%+2.6%−46.3%
−23.5%−21.1%−28.9%
−22.7%−60.6%+42.0%
+2.9%+11.1%−26.6%
+2.0%+17.3%−24.5%
+6.8%−20.0%−11.3%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

GHCL₹388.70

GHCL Ltd.

· Chemicals
₹ CrorePeersTATACHEMGNFCGSFCELLENTECILCHEMBALAMINESLXCHEMALKYLAMINEMcap ₹3,573 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue Growth—-24.2-7.6-3.7—
EBITDA Growth—-42.8+3.4-21.4—
EBIT Growth—-46.3+2.6-24.4—
Net Income Growth—-28.9-21.1-23.5—
EPS Growth—+42.0-60.6-22.7—
Total Assets Growth—-26.6+11.1+2.9—
Total Equity Growth—-24.5+17.3+2.0—
Cash from Operations Growth—-11.3-20.0+6.8—
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.